Bowen Hanes & Co’s AstraZeneca AZN Stock Holding History

Bowen Hanes & Co’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-100,000	Closed	-$6.79M	–	128
2015 Q4	$6.79M	Buy	+100,000	New	+$6.56M	0.38%	75

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Bowen Hanes & Co's AZN Position: Q1 2016 in Review

Bowen Hanes & Co sold out of AstraZeneca (AZN) in Q1 2016, closing a stake of 100,000 shares — an estimated $6.79M sold.

Bowen Hanes & Co first reported a position in AZN in Q4 2015 and held it in 1 quarter. The position peaked at $6.79M in Q4 2015. 390 funds tracked by Wall St. Rank hold AZN as of Q1 2016.

Bowen Hanes & Co reported no remaining AstraZeneca position as of Q1 2016 after selling out during the quarter.
Bowen Hanes & Co sold 100,000 AstraZeneca shares in Q1 2016, an estimated $6.79M.
Bowen Hanes & Co first reported a position in AstraZeneca in Q4 2015 and held it in 1 quarter.
Bowen Hanes & Co's AstraZeneca position peaked at $6.79M in Q4 2015.
390 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2016.

Based on Bowen Hanes & Co's 13F filing for Q1 2016, filed 16 May 2016.